[Risks in the treatment of parkinsonism with l-dopa and a dopa decarboxylase inhibitor].
D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001812:Blood-Brain Barrier; D004296:Dopa Decarboxylase; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D004791:Enzyme Inhibitors; D007980:Levodopa; D004296:Dopa Decarboxylase
Risiken der Parkinsonbehandlung mit L-Dopa und einem Dopadecarboxylase-Hemmer.